Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applications

Ahmad Aljada1, Lynn Dong, Shaker A Mousa

  • 1Long Island University, Department of Biomedical Sciences, Brookville, NY 11548, USA.

Current Opinion in Investigational Drugs (London, England : 2000)
|September 28, 2010
PubMed

Insights

Sirtuins, NAD+-dependent deacetylases, regulate key cellular processes like metabolism and neurodegeneration. Understanding sirtuin mechanisms may lead to new therapies for diseases including cancer and Alzheimer's.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cellular Biology

Background:

  • Sirtuins are NAD+-dependent histone/protein deacetylases homologous to yeast Sir2.
  • They play crucial roles in regulating diverse cellular and metabolic processes.
  • Dysregulation of sirtuin activity is implicated in tumorigenesis, neurodegeneration, type 2 diabetes, obesity, and aging.

Purpose of the Study:

  • To review the regulatory mechanisms governing sirtuin activity.
  • To explore how sirtuin activity can be manipulated for therapeutic benefit in pathological conditions.
  • To discuss the metabolic consequences of pharmacological sirtuin modulation.

Main Methods:

  • Literature review of sirtuin research.
  • Analysis of known sirtuin activators and inhibitors.
  • Discussion of pathological states linked to sirtuin function.

Main Results:

  • Sirtuins are involved in fundamental cellular functions and disease pathways.
  • Numerous small-molecule and natural compounds modulate sirtuin activity.
  • Understanding regulatory mechanisms offers therapeutic potential.

Conclusions:

  • Targeting sirtuin activity presents a promising avenue for novel therapeutic strategies.
  • Pharmacological manipulation of sirtuins could impact metabolic diseases, cancer, and neurodegenerative disorders.
  • Further research into sirtuin regulation is warranted for clinical applications.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...